Glox Therapeutics Ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
Company Details
- Employees
- 13
- Founded
- 2023
- Address
- Glasgow, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- gla.ac.uk.
- HQ
- Glasgow
Glox Therapeutics Ltd. Questions
Glox Therapeutics Ltd.'s LinkedIn profile is https://uk.linkedin.com/company/glox-therapeutics-ltd
Glox Therapeutics Ltd. has
13 employees.
View email and phone details for 13
employees at Glox Therapeutics Ltd..
Glox Therapeutics Ltd.'s industry is
Biotechnology Research
Glox Therapeutics Ltd.'s top competitors are
Bioascent,
Xiretsa,
Obulytix,
Mironid® Limited,
Matchbio,
Arrepath,
Pace-Amr,
Causeway Therapeutics,
Enough,
Tc Biopharm.
Glox Therapeutics Ltd.'s categories are Biotechnology Research
Glox Therapeutics Ltd.'s founding year is 2023
